APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population

Journal of Nutrition

Volumn 141, Issue 3, 2011, Pages 380-385

  Sánchez Moreno, Carmen ^a   Ordovás, Jose M ^b,c   Smith, Caren E ^b   Baraza, Juan C ^a   Lee, Yu Chi ^b   Garaulet, Marta ^a,b  

^a UNIVERSITY OF MURCIA   (Spain)

^b TUFTS UNIVERSITY   (United States)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A5; FAT; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ALLELE; ANTHROPOMETRY; ARTICLE; BODY MASS; CONTROLLED STUDY; FAT INTAKE; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; APOLIPOPROTEINS A; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIETARY FATS; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; HYPERTRIGLYCERIDEMIA; LIPOPROTEINS; LIPOPROTEINS, VLDL; MALE; MEDITERRANEAN REGION; MIDDLE AGED; OBESITY; OVERWEIGHT; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; SPAIN; TRIGLYCERIDES; YOUNG ADULT;

EID: 79951996818     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.110.130344     Document Type: Article

References (49)

1. Brewer HB. Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease. Am J Cardiol. 1999;83:F3-12.
2. Ginsberg HN. Identification and treatment of hypertriglyceridemia as a risk factor for coronary heart disease. Curr Cardiol Rep. 1999;1:233-7.
3. Austin MA. Epidemiology of hypertriglyceridemia and cardiovascular disease. Am J Cardiol. 1999;83:F13-6.
4. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298:299-308. (Pubitemid 47080484)
5. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, Krauss RM, Rubin EM. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 2001;294:169-73. (Pubitemid 32952971)
6. Tai ES, Ordovas JM. Clinical significance of apolipoprotein A5. Curr Opin Lipidol. 2008;19:349-54.
7. Perez-Martinez P, Corella D, Shen J, Arnett DK, Yiannakouris N, Tai ES, Orho-Melander M, Tucker KL, Tsai M, et al. Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states. Am J Clin Nutr. 2009;89:391-9.
8. Corella D, Ordovas JM. Single nucleotide polymorphisms that influence lipid metabolism: interaction with dietary factors. Annu Rev Nutr. 2005;25:341-90. (Pubitemid 41209006)
9. Yang Q, Khoury MJ. Evolving methods in genetic epidemiology. III. Gene-environment interaction in epidemiologic research. Epidemiol Rev. 1997;19:33-43.
10. Khoury MJ, Davis R, Gwinn M, Lindegren ML, Yoon P. Do we need genomic research for the prevention of common diseases with environmental causes? Am J Epidemiol. 2005;161:799-805.
11. Hunter DJ. Gene-environment interactions in human diseases. Nat Rev Genet. 2005;6:287-98. (Pubitemid 40469048)
12. Grigorenko EL. The inherent complexities of gene-environment interactions. J Gerontol B Psychol Sci Soc Sci. 2005;60:53-64.
13. Ordovas JM, Corella D. Nutritional genomics. Annu Rev Genomics Hum Genet. 2004;5:71-118. (Pubitemid 39362742)
14. Elosua R, Ordovas JM, Cupples LA, Lai CQ, Demissie S, Fox CS, Polak JF, Wolf PA, D'Agostino RB, et al. Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Study. J Lipid Res. 2006;47:990-6. (Pubitemid 43764695)
15. Corella D, Lai CQ, Demissie S, Cupples LA, Manning AK, Tucker KL, Ordovas JM. APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study. J Mol Med. 2007;85:119-28. (Pubitemid 46183611)
16. Mattei J, Demissie S, Tucker KL, Ordovas JM. Apolipoprotein A5 polymorphisms interact with total dietary fat intake in association with markers of metabolic syndrome in Puerto Rican older adults. J Nutr. 2009;139:2301-8.
17. Aberle J, Evans D, Beil FU, Seedorf U. A polymorphism in the apolipoprotein A5 gene is associated with weight loss after short-term diet. Clin Genet. 2005;68:152-4. (Pubitemid 40990626)
18. Kim JY, Kim OY, Koh SJ, Jang Y, Yun SS, Ordovas JM, Lee JH. Comparison of low-fat meal and high-fat meal on postprandial lipemic response in non-obese men according to the -1131T.C polymorphism of the apolipoprotein A5 (APOA5) gene (randomized cross-over design). J Am Coll Nutr. 2006;25:340-7. (Pubitemid 44414701)
19. Lai CQ, Corella D, Demissie S, Cupples LA, Adiconis X, Zhu Y, Parnell LD, Tucker KL, Ordovas JM. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study. Circulation. 2006;113:2062-70.
20. Hubacek JA, Bohuslavova R, Skodova Z, Pitha J, Bobkova D, Poledne R. Polymorphisms in the APOA1/C3/A4/A5 gene cluster and cholesterol responsiveness to dietary change. Clin Chem Lab Med. 2007;45:316-20. (Pubitemid 46480892)
21. Salas-Salvadó J, Fernández-Ballart J, Ros E, Martínez-González MA, Fitó M, Estruch R, Corella D, Fiol M, Gómez-Gracia E, et al. Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial. Arch Intern Med. 2008;168:2449-58.
22. Sánchez-Taínta A, Estruch R, Bulló M, Corella D, Gómez-Gracia E, Fiol M, Algorta J, Covas MI, Lapetra J, et al. Adherence to a Mediterranean-type diet and reduced prevalence of clustered cardiovascular risk factors in a cohort of 3,204 high-risk patients. Eur J Cardiovasc Prev Rehabil. 2008;15:589-93.
23. Parnell LD, Lee YC, Lai CQ. Adaptive genetic variation and heart disease risk. Curr Opin Lipidol. 2010;21:116-22.
24. Ordovas JM, Kaput J, Corella D. Nutrition in the genomics era: cardiovascular disease risk and the Mediterranean diet. Mol Nutr Food Res. 2007;51:1293-9. (Pubitemid 350013176)
25. Ferrario VF, Sforza C, Schmitz JH, Miani A, Taroni G. Fourier analysis of human soft tissue facial shape: Sex differences in normal adults. J Anat. 1995;187:593-602. (Pubitemid 26015731)
26. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345-53.
27. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg21 precipitation procedure for quantitation of high-densitylipoprotein cholesterol. Clin Chem. 1982;28:1379-88. (Pubitemid 12125081)
28. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
29. Zimmet P,Magliano D,Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb. 2005;12:295-300.
30. Perez-Llamas F, Garaulet M, Herrero F, Palma JT, Perez de Heredia F, Marin R, Zamora S. Multivalent informatics application for studies of the nutricional status of the population. Assessment of food intake. Nutr Hosp. 2004;19:160-6.
31. Mataix J, Mañas M, Llopis J, Martínez E. Tabla de composición de alimentos españoles. Granada, Spain: Instituto de Nutrición y Tecnología, Universidad de Granada; 1995.
32. Moreiras O, Carvajal A, Cabrera L. Tablas de composición de alimentos. In: Ediciones Pirámide, SA. Madrid. 1995.
33. HelixTree Manual. Version 5.3.0. [Internet]; updated 2010 Jul 1 [cited 2010 Jul 16]. Available from: http://goldenhelix.com/HelixTreeManual/ compositehaplotypemethodchm.html#x133-75400023.7.
34. Departamento de Nutrición y Bromatología I. Tablas recomendadas de energía y nutrientes para la población española. Universidad Complutense de Madrid. Madrid; 1994.
35. Martinelli N, Trabetti E, Bassi A, Girelli D, Friso S, Pizzolo F, Sandri M, Malerba G, Pignatti PF, et al. The -1131 T.C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study. Atherosclerosis. 2007;191:409-17. (Pubitemid 46400704)
36. Garaulet M, Perez-Llamas F, Canteras M, Tebar FJ, Zamora S. Endocrine, metabolic and nutritional factors in obesity and their relative significance as studied by factor analysis. Int J Obes Relat Metab Disord. 2001;25:243-51.
37. Hill JO, Melanson EL, Wyatt HT. Dietary fat intake and regulation of energy balance: implications for obesity. J Nutr. 2000;130(2S Suppl): 284S-288S.
38. Willett WC. Dietary fat and obesity: an unconvincing relation. Am J Clin Nutr. 1998;68:1149-50. (Pubitemid 28550940)
39. Willet WC. Is dietary fat a major determinant of body fat? Am J Clin Nutr. 1998;67 (Suppl 3):S556-62.
40. Fruchart-Najib J, Bauge E, Niculescu LS, Pham T, Thomas B, Rommens C, Majd Z, Brewer B, Pennacchio LA, et al. Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5. Biochem Biophys Res Commun. 2004;319:397-404. (Pubitemid 38725960)
41. Prieur X, Coste H, Rodriguez JC. The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element. J Biol Chem. 2003;278:25468-80. (Pubitemid 36835298)
42. Prieur X, Huby T, Coste H, Schaap FG, Chapman MJ, Rodriguez JC. Thyroid hormone regulates the hypotriglyceridemic gene APOA5. J Biol Chem. 2005;280:27533-43. (Pubitemid 41076864)
43. Memisoglu A, Hu FB, Hankinson SE, Manson JE, De Vivo I, Willett WC, Hunter DJ. Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet. 2003;12:2923-9. (Pubitemid 37442020)
44. Hallman DM, Srinivasan SR, Chen W, Boerwinkle E, Berenson GS. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study. Metabolism. 2006;55: 1574-81. (Pubitemid 44827122)
45. Jang Y, Paik JK, Hyun YJ, Chae JS, Kim JY, Choi JR, Lee SH, Shin DJ, Ordovas JM, et al. The apolipoprotein A5-1131TNC promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease. Clin Chim Acta. 2009;402:83-7.
46. Schaap FG, Rensen PC, Voshol PJ, Vrins C, Van der Vlie HN, Chamuleau RA, Havekes LM, Groen AK, van Dijk KW. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J Biol Chem. 2004;279: 27941-7. (Pubitemid 38900062)
47. Merkel M, Loeffler B, Kluger M, Fabig N, Geppert G, Pennacchio LA, Laatsch A, Heeren J. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan bound lipoprotein lipase. J Biol Chem. 2005;280:21553-60. (Pubitemid 40805722)
48. Lookene A, Beckstead JA, Nilsson S, Olivecrona G, Ryan RO. Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism. J Biol Chem. 2005;280:25383-7. (Pubitemid 40962241)
49. Nilsson SK, Lookene A, Beckstead JA, Gliemann J, Ryan RO, Olivecrona G. Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family. Biochemistry. 2007;46: 3896-904. (Pubitemid 46493490)